The Analysis Study of Relationship of Psoriasis and Hypertension: A Comprehensive Systematic Review
Keywords:
hypertension, psoriasis, relationship, cardiovascular, inflammatoryAbstract
Background: Psoriasis patients have a higher prevalence of hypertension, a significant risk factor for cardiovascular disease. The association between psoriasis and hypertension is complex, with psoriasis often presenting with additional risk factors. Treatment approaches are complex, and understanding the bidirectional relationship between psoriasis and hypertension is crucial for optimizing treatment strategies and improving patient care. Methods: This systematic review adhered to PRISMA 2020 guidelines, focusing exclusively on full-text articles published in English between 2014 and 2024. Editorials and review articles without a DOI were excluded to ensure the utilization of high-quality sources. A literature review was conducted utilizing reputable databases including ScienceDirect, PubMed, and SagePub to identify relevant studies. Result: The initial database search yielded over 1,000 relevant publications on the topic. Following a rigorous three-stage screening process, eight studies met the predefined inclusion criteria and were selected for in-depth analysis. Each study underwent a comprehensive critical evaluation, enabling a thorough examination of the relationship between psoriasis and hypertension. This systematic approach ensured that the analysis was grounded in high-quality evidence, closely aligned with the study's objectives, and capable of providing meaningful insights into this complex association. Conclusion: Psoriasis and hypertension are linked due to various factors, including confounding variables, shared inflammatory pathways, and treatment-related factors. Further research is needed to understand causal mechanisms and the impact of disease severity on hypertension risk. Understanding these factors will help healthcare providers develop personalized treatment approaches and improve patient outcomes for those affected by both conditions.
References
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith, S. C., Jr, Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T., Jr, Narva, A. S., & Ortiz, E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5), 507–520. https://doi.org/10.1001/jama.2013.284427
Zhang, Y., & Moran, A. E. (2017). Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014. Hypertension (Dallas, Tex. : 1979), 70(4), 736–742. https://doi.org/10.1161/HYPERTENSIONAHA.117.09801
Omboni S. (2019). Connected Health in Hypertension Management. Frontiers in cardiovascular medicine, 6, 76. https://doi.org/10.3389/fcvm.2019.00076
Puig L. (2017). Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis. International journal of molecular sciences, 19(1), 58. https://doi.org/10.3390/ijms19010058
Kampe, T., Dorko, E., Rimárová, K., Houžvičková, A., Baloghová, J., Baranová, Z., Madleňák, M., & Rohoň, I. (2022). Prevalence of cardiovascular risk factors in patients with psoriasis. Central European journal of public health, 30(Supplement), S05–S10. https://doi.org/10.21101/cejph.a6806
Baeta, I. G., Bittencourt, F. V., Gontijo, B., & Goulart, E. M. (2014). Comorbidities and cardiovascular risk factors in patients with psoriasis. Anais brasileiros de dermatologia, 89(5), 735–744. https://doi.org/10.1590/abd1806-4841.20142874
Richard, M. A., Barnetche, T., Horreau, C., Brenaut, E., Pouplard, C., Aractingi, S., Aubin, F., Cribier, B., Joly, P., Jullien, D., Le Maître, M., Misery, L., Ortonne, J. P., & Paul, C. (2013). Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion. Journal of the European Academy of Dermatology and Venereology : JEADV, 27 Suppl 3, 2–11. https://doi.org/10.1111/jdv.12162
Alhomoud, A. S., Alnemer, K. A., Aldokheal, M. I., Alsultan, A. M., & Alzahrani, Z. K. (2017). The prevalence of cardiovascular diseases risk factors associated with psoriasis in Saudi Arabia. Electronic physician, 9(11), 5793–5799. https://doi.org/10.19082/5793
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017). Psoriasis and comorbid diseases: Implications for management. Journal of the American Academy of Dermatology, 76(3), 393–403. https://doi.org/10.1016/j.jaad.2016.07.065
Balak, D. M., & Hajdarbegovic, E. (2017). Drug-induced psoriasis: clinical perspectives. Psoriasis (Auckland, N.Z.), 7, 87–94. https://doi.org/10.2147/PTT.S126727
Salihbegovic, E. M., Hadzigrahic, N., Suljagic, E., Kurtalic, N., Sadic, S., Zejcirovic, A., & Mujacic, A. (2015). Psoriasis and high blood pressure. Medical archives (Sarajevo, Bosnia and Herzegovina), 69(1), 13–15. https://doi.org/10.5455/medarh.2015.69.13-15
Takeshita, J., Wang, S., Shin, D. B., Mehta, N. N., Kimmel, S. E., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2015). Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA dermatology, 151(2), 161–169. https://doi.org/10.1001/jamadermatol.2014.2094
Kim, H. N., Han, K., Song, S. W., & Lee, J. H. (2018). Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study. PloS one, 13(8), e0202854. https://doi.org/10.1371/journal.pone.0202854
deShazo, R. A., Secrest, A. M., Armstrong, A. W., & Duffin, K. C. (2020). Addressing hypertension in patients with psoriasis: Review and recommendations. Journal of Psoriasis and Psoriatic Arthritis, 5(4), 129–138. https://doi.org/10.1177/2475530320936373
Duan, X., Liu, J., Mu, Y., Liu, T., Chen, Y., Yu, R., Xiong, X., & Wu, T. (2020). A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates. Medicine, 99(9), e19303. https://doi.org/10.1097/MD.0000000000019303
Hu, M. Y., Yang, Q., & Zheng, J. (2020). The association of psoriasis and hypertension: focusing on anti-inflammatory therapies and immunological mechanisms. Clinical and experimental dermatology, 45(7), 836–840. https://doi.org/10.1111/ced.14327
Masson, W., Lobo, M., & Molinero, G. (2020). Psoriasis and Cardiovascular Risk: A Comprehensive Review. Advances in therapy, 37(5), 2017–2033. https://doi.org/10.1007/s12325-020-01346-6
Gumilang, R., Widyaswari, M. S., & Husin, Z. R. (2021). Psoriasis Relationship with Hypertension in Psoriasis Patients at RSI Jemursari Surabaya. Jurnal Kesehatan Islam Islamic Health Journal, 10(2), 72. https://doi.org/10.33474/jki.v10i2.13827
Li, W., Han, J., Hu, F. B., Curhan, G. C., & Qureshi, A. A. (2012). Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study. The Journal of investigative dermatology, 132(2), 291–298. https://doi.org/10.1038/jid.2011.319
Osigwe, P. C., Agomoh, C. E., Osigwe, I. S., & Akumiah, F. K. (2024). The Association Between Psoriasis and Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis of Observational Studies. Cureus, 16(6), e63379. https://doi.org/10.7759/cureus.63379
Korman N. J. (2020). Management of psoriasis as a systemic disease: what is the evidence?. The British journal of dermatology, 182(4), 840–848. https://doi.org/10.1111/bjd.18245
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013). The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. Journal of hypertension, 31(3), 433–443. https://doi.org/10.1097/HJH.0b013e32835bcce1
Schön M. P. (2019). Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders. Frontiers in immunology, 10, 1764. https://doi.org/10.3389/fimmu.2019.01764
Virdis, A., Duranti, E., & Taddei, S. (2011). Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II. International journal of hypertension, 2011, 916310. https://doi.org/10.4061/2011/916310
Armstrong, A. W., Voyles, S. V., Armstrong, E. J., Fuller, E. N., & Rutledge, J. C. (2011). Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. Journal of dermatological science, 63(1), 1–9. https://doi.org/10.1016/j.jdermsci.2011.04.007
Ni, C., & Chiu, M. W. (2014). Psoriasis and comorbidities: links and risks. Clinical, cosmetic and investigational dermatology, 7, 119–132. https://doi.org/10.2147/CCID.S44843
Al-Mutairi, N., Al-Farag, S., Al-Mutairi, A., & Al-Shiltawy, M. (2010). Comorbidities associated with psoriasis: an experience from the Middle East. The Journal of dermatology, 37(2), 146–155. https://doi.org/10.1111/j.1346-8138.2009.00777.x
Langan, S. M., Seminara, N. M., Shin, D. B., Troxel, A. B., Kimmel, S. E., Mehta, N. N., Margolis, D. J., & Gelfand, J. M. (2012). Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. The Journal of investigative dermatology, 132(3 Pt 1), 556–562. https://doi.org/10.1038/jid.2011.365
Mente, A., O'Donnell, M., Rangarajan, S., McQueen, M., Dagenais, G., Wielgosz, A., Lear, S., Ah, S. T. L., Wei, L., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., Mony, P., Szuba, A., Iqbal, R., Yusuf, R., Mohammadifard, N., Khatib, R., Yusoff, K., … Yusuf, S. (2018). Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet (London, England), 392(10146), 496–506. https://doi.org/10.1016/S0140-6736(18)31376-X
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Melinda Angelin, Muhammad Faiz Haidar Rafi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
